Clinical Trial
A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients
- PMID: 803428
Item in Clipboard
Clinical Trial
A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients
Curr Ther Res Clin Exp.
1975 Feb.
No abstract available
Similar articles
-
Controlled clinical evaluation of a new anorectic agent in obese adults.Pa Med. 1974 Sep;77(9):46-50. Pa Med. 1974. PMID: 4609056 Clinical Trial. No abstract available.
-
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].Ter Arkh. 1981;53(7):142-51. Ter Arkh. 1981. PMID: 6457407 Review. Russian. No abstract available.
-
Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:265-8. Arzneimittelforschung. 1972. PMID: 4553235 Clinical Trial. No abstract available.
-
[2-(4-Isobutylphenyl)-propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance].Minerva Med. 1973 Jun 23;64(47):2513-4. Minerva Med. 1973. PMID: 4579843 Clinical Trial. Italian. No abstract available.
-
[Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].Ter Arkh. 2003;75(5):64-70. Ter Arkh. 2003. PMID: 12847902 Review. Russian. No abstract available.
Cited by
-
Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis.Ann Rheum Dis. 2007 Apr;66(4):433-9. doi: 10.1136/ard.2006.065904. Epub 2007 Jan 4. Ann Rheum Dis. 2007. PMID: 17204567 Free PMC article.
-
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.Clinics (Sao Paulo). 2017 May;72(5):317-324. doi: 10.6061/clinics/2017(05)10. Clinics (Sao Paulo). 2017. PMID: 28591345 Free PMC article.